Comparison of the Adult Comorbidity Evaluation 27 and the Charlson Comorbidity indices in patients with laryngeal squamous cell carcinoma

Journal of Laryngology and Otology

Volumn 126, Issue 5, 2012, Pages 516-524

  Nesic, V S ^a   Petrovic, Z M ^a   Sipetic, S B ^a   Jesic, S D ^a   Soldatovic, I A ^a   Kastratovic, D A ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Comorbidity; Laryngeal Neoplasms; Squamous Cell Carcinoma; Survival Analysis

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; UNIVARIATE ANALYSIS;

ADULT; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84860798151     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215112000254     Document Type: Article

References (25)

1. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974;27:387-404
2. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-83 (Pubitemid 17055592)
3. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR. New clinical severity staging system for cancer of the larynx. Ann Otol Rhinol Laryngol 1994;103:83-92 (Pubitemid 24072265)
4. Linn BS, Linn MW, Lee G. Cumulative illness rating scale. J Am Geriatr Soc 1968;5:622-6
5. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 1993;31:141-54
6. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-67 (Pubitemid 32007842)
7. Piccirillo JF, Creech CM, Zequeira R, Anderson S, Johnston AS. Inclusion of comorbidity into oncology data registries. Journal of Registry Management 1999;26:66-70
8. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000;110:593-602 (Pubitemid 30198711)
9. Paleri V, Wight RG, Davies GR. Impact of comorbidity on the outcome of laryngeal squamous cancer. Head Neck 2003;25: 1019-26 (Pubitemid 37475264)
10. Castro MA, Dedivitis RA, Ribeiro KC. Comorbidity measurement in patients with laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2007;69:146-52 (Pubitemid 46597289)
11. Chen AY, Matson LK, Roberts D, Goepfert H. The significance of comorbidity in advanced laryngeal cancer. Head Neck 2001; 23:566-72 (Pubitemid 32565530)
12. Piccirillo JF, Lacy PD, Basu A, Spitznagel EL. Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 2002;128:1172-9 (Pubitemid 35168108)
13. Cleves MA, Sanchez N, Draheim M. Evaluation of two competing methods for calculating Charlson's comorbidity index when analyzing short-term mortality using administrative data. J Clin Epidemiol 1997;50:903-8 (Pubitemid 27423520)
14. Sabin SL, Rosefeld RM, Sundaram K, Har-El G, Lucente FE. The impact of comorbidity and age on survival with laryngeal cancer. Ear Nose Throat J 1999;78:578, 581-4
15. Head and Neck. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2010;57-68
16. Datema FR, Ferrier MB, van der Schroeff MP, Baatenburg de Jong RJ. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients. Head Neck 2010;32:728-36
17. Paleri V, Narayan R, Wight RG. Descriptive study of the type and severity of decompensation caused by comorbidity in a population of patients with laryngeal squamous cancer. J Laryngol Otol 2004;118:517-21 (Pubitemid 39061784)
18. Singh B, Bhaya M, Zimbler M, Stern J, Roland JT, Rosenfeld RM et al. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 1998; 20:1-7
19. Singh B, Bhaya M, Stern J, Roland JT, Zimbler M, Rosenfeld RM et al. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997;107:1469-75 (Pubitemid 27481468)
20. Paleri V, Wight RG. Applicability of the Adult Comorbidity Evaluation-27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study. J Laryngol Otol 2002;116:200-5 (Pubitemid 34214430)
21. Hall SF, Rochon PA, Streiner DL, Paszat LF, Groome PA, Rohland SL. Measuring comorbidity in patients with head and neck cancer. Laryngoscope 2002;112:1988-96 (Pubitemid 35283461)
22. Piccirillo JF, Spitznagel EL Jr, Vermani N, Costas I, Schnitzler M. Comparison of comorbidity indices for patients with head and neck cancer. Med Care 2004;42:482-6
23. Montero EH, Trufero JM, Romeo JA, Terré FC. Comorbidity and prognosis in advanced hypopharyngeal-laryngeal cancer under combined therapy. Tumori 2008;94:24-9 (Pubitemid 351487181)
24. Cascorbi I. The promises of personalized medicine. Eur J Clin Pharmacol 2010;66:749-54
25. Paleri V, Wight RG. A cross-comparison of retrospective notes extraction and combined notes extraction and patient interview in the completion of a comorbidity index (ACE-27) in a cohort of United Kingdom patients with head and neck cancer. J Laryngol Otol 2002;116: 937-41 (Pubitemid 35370446)